东南大学学报(医学版)
東南大學學報(醫學版)
동남대학학보(의학판)
JOURNAL OF SOUTHEAST UNIVERSITY(MEDICAL SCIENCE EDITION)
2015年
1期
44-46
,共3页
袁维栋%顾殿华%张建淮%王业波%祁付珍%吴金声%刘玲
袁維棟%顧殿華%張建淮%王業波%祁付珍%吳金聲%劉玲
원유동%고전화%장건회%왕업파%기부진%오금성%류령
大肝癌%肝癌切除术%肝癌术后复发%缓释型氟尿嘧啶
大肝癌%肝癌切除術%肝癌術後複髮%緩釋型氟尿嘧啶
대간암%간암절제술%간암술후복발%완석형불뇨밀정
large liver cancer%liver cancer operation%recurrence after liver cancer operation%sustained-release 5-fluorouracil
目的::研究术中植入氟尿嘧啶缓释剂对大肝癌术后复发的预防作用。方法:对我院收治的100例大肝癌手术患者进行前瞻性临床随机对照研究,分为实验组和对照组,各50例。实验组在术中行肝切除创面和大网膜氟尿嘧啶缓释剂植入。观察两组术前一般资料,术后肝肾功能,出血、胆漏、切口裂开等手术并发症,恶心呕吐、白细胞下降等化疗不良反应,以及1年、3年复发率和生存时间。结果:两组间术后手术并发症、化疗相关不良反应差异均无统计学意义(均P>0.05)。实验组1年、3年的复发率分别为34%和54%,对照组分别为42%和70%,两组间差异无统计学意义(P>0.05)。两组生存函数间差异有统计学意义(P<0.05)。结论:术中植入缓释型氟尿嘧啶安全可行,可延长患者生存时间。
目的::研究術中植入氟尿嘧啶緩釋劑對大肝癌術後複髮的預防作用。方法:對我院收治的100例大肝癌手術患者進行前瞻性臨床隨機對照研究,分為實驗組和對照組,各50例。實驗組在術中行肝切除創麵和大網膜氟尿嘧啶緩釋劑植入。觀察兩組術前一般資料,術後肝腎功能,齣血、膽漏、切口裂開等手術併髮癥,噁心嘔吐、白細胞下降等化療不良反應,以及1年、3年複髮率和生存時間。結果:兩組間術後手術併髮癥、化療相關不良反應差異均無統計學意義(均P>0.05)。實驗組1年、3年的複髮率分彆為34%和54%,對照組分彆為42%和70%,兩組間差異無統計學意義(P>0.05)。兩組生存函數間差異有統計學意義(P<0.05)。結論:術中植入緩釋型氟尿嘧啶安全可行,可延長患者生存時間。
목적::연구술중식입불뇨밀정완석제대대간암술후복발적예방작용。방법:대아원수치적100례대간암수술환자진행전첨성림상수궤대조연구,분위실험조화대조조,각50례。실험조재술중행간절제창면화대망막불뇨밀정완석제식입。관찰량조술전일반자료,술후간신공능,출혈、담루、절구렬개등수술병발증,악심구토、백세포하강등화료불량반응,이급1년、3년복발솔화생존시간。결과:량조간술후수술병발증、화료상관불량반응차이균무통계학의의(균P>0.05)。실험조1년、3년적복발솔분별위34%화54%,대조조분별위42%화70%,량조간차이무통계학의의(P>0.05)。량조생존함수간차이유통계학의의(P<0.05)。결론:술중식입완석형불뇨밀정안전가행,가연장환자생존시간。
Objective:To explore the effect of implanting sustained-release 5-fluorouracil during hepatectomy on the recurrence of large liver cancer. Methods:100 liver cancer patients undergoing hepatectomy were divided into experimental group ( n = 50 ) and control group ( n = 50 ) . Operative complications, adverse reaction of chemotherapy, recurrence rate and survival time were compared between the two groups. Results: There were no difference in operative complications and adverse reaction of chemotherapy between the two groups. All the cases were followed up for more than 3 years. 1-,3-year recurrence rates were 34% and 54% in experimental group respectively, 42% and 70% in control group respectively. There were no difference between them(P>0. 05). Survival time of experimental group was longer than control group with statistical difference ( P< 0 . 05 ) . Conclusion:Implanting sustained-release 5-fluorouracil can be used saftly during large liver cancer operation and can prolong survival time.